

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.48102319 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.48102319 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.48102319 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.48102319 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.48102319 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.48102319 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.30947465 |
| 8 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.26098666 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.17048613 |
| 10 | positive regulation of interferon-alpha production (GO:0032727) | 4.07387281 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.92782725 |
| 12 | regulation of interferon-alpha production (GO:0032647) | 3.91883993 |
| 13 | regulation of integrin activation (GO:0033623) | 3.77352686 |
| 14 | apoptotic cell clearance (GO:0043277) | 3.50368627 |
| 15 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.45579421 |
| 16 | low-density lipoprotein particle clearance (GO:0034383) | 3.44915435 |
| 17 | response to host immune response (GO:0052572) | 3.44559893 |
| 18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.44559893 |
| 19 | response to peptidoglycan (GO:0032494) | 3.39742439 |
| 20 | regulation of vitamin metabolic process (GO:0030656) | 3.38551436 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37516294 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37516294 |
| 23 | regulation of cholesterol storage (GO:0010885) | 3.37245127 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.32424087 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32011955 |
| 26 | germinal center formation (GO:0002467) | 3.29292412 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29182949 |
| 28 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.25111607 |
| 29 | response to host (GO:0075136) | 3.25111607 |
| 30 | response to host defenses (GO:0052200) | 3.25111607 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.22760087 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.22760087 |
| 33 | regulation of mononuclear cell migration (GO:0071675) | 3.22530367 |
| 34 | positive regulation of interferon-beta production (GO:0032728) | 3.13985575 |
| 35 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.11810008 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.09447164 |
| 37 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.08738398 |
| 38 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.05463018 |
| 39 | cell adhesion mediated by integrin (GO:0033627) | 3.03805485 |
| 40 | neutrophil activation involved in immune response (GO:0002283) | 3.03630739 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02829003 |
| 42 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.01462482 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.00393595 |
| 44 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.99837643 |
| 45 | detection of other organism (GO:0098543) | 2.97903847 |
| 46 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97570102 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 2.95224896 |
| 48 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.95013301 |
| 49 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.94656197 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.93337842 |
| 51 | response to muramyl dipeptide (GO:0032495) | 2.90649817 |
| 52 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.90221149 |
| 53 | response to type I interferon (GO:0034340) | 2.85841656 |
| 54 | regulation of chemokine biosynthetic process (GO:0045073) | 2.84901568 |
| 55 | type I interferon signaling pathway (GO:0060337) | 2.84724638 |
| 56 | cellular response to type I interferon (GO:0071357) | 2.84724638 |
| 57 | T-helper 1 type immune response (GO:0042088) | 2.84662838 |
| 58 | I-kappaB phosphorylation (GO:0007252) | 2.82141294 |
| 59 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.80630146 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80379438 |
| 61 | stress fiber assembly (GO:0043149) | 2.80082589 |
| 62 | detection of external biotic stimulus (GO:0098581) | 2.78940304 |
| 63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78818068 |
| 64 | positive regulation of p38MAPK cascade (GO:1900745) | 2.78202931 |
| 65 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.76830249 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.76829864 |
| 67 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.72939929 |
| 68 | regulation of fever generation (GO:0031620) | 2.72187328 |
| 69 | leukocyte cell-cell adhesion (GO:0007159) | 2.71074638 |
| 70 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.71028645 |
| 71 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.70635437 |
| 72 | chronic inflammatory response (GO:0002544) | 2.69872795 |
| 73 | positive regulation of type 2 immune response (GO:0002830) | 2.66290445 |
| 74 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.65227358 |
| 75 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.64525833 |
| 76 | cellular response to lipopolysaccharide (GO:0071222) | 2.62789737 |
| 77 | response to interferon-alpha (GO:0035455) | 2.61347429 |
| 78 | cellular extravasation (GO:0045123) | 2.60230539 |
| 79 | modulation by symbiont of host cellular process (GO:0044068) | 2.59363259 |
| 80 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.58851796 |
| 81 | macrophage activation (GO:0042116) | 2.58275401 |
| 82 | positive regulation of heat generation (GO:0031652) | 2.58229283 |
| 83 | detection of molecule of bacterial origin (GO:0032490) | 2.58065729 |
| 84 | hypotonic response (GO:0006971) | 2.57918001 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.57737173 |
| 86 | establishment of endothelial barrier (GO:0061028) | 2.57243280 |
| 87 | response to laminar fluid shear stress (GO:0034616) | 2.57145852 |
| 88 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.56978673 |
| 89 | cellular response to molecule of bacterial origin (GO:0071219) | 2.56837888 |
| 90 | positive regulation of antigen processing and presentation (GO:0002579) | 2.56653334 |
| 91 | detection of biotic stimulus (GO:0009595) | 2.56349601 |
| 92 | respiratory burst (GO:0045730) | 2.56100531 |
| 93 | regulation of macrophage cytokine production (GO:0010935) | 2.54956382 |
| 94 | detection of bacterium (GO:0016045) | 2.54624505 |
| 95 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.54028039 |
| 96 | regulation of podosome assembly (GO:0071801) | 2.53911020 |
| 97 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.52111163 |
| 98 | regulation of macrophage chemotaxis (GO:0010758) | 2.52043327 |
| 99 | myeloid dendritic cell differentiation (GO:0043011) | 2.51918283 |
| 100 | barbed-end actin filament capping (GO:0051016) | 2.51510878 |
| 101 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.49624106 |
| 102 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.49433235 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 2.48985641 |
| 104 | regulation of type 2 immune response (GO:0002828) | 2.48977910 |
| 105 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.48616015 |
| 106 | positive regulation of macrophage cytokine production (GO:0060907) | 2.48603006 |
| 107 | granulocyte activation (GO:0036230) | 2.47737257 |
| 108 | regulation of chronic inflammatory response (GO:0002676) | 2.47683645 |
| 109 | regulation of interferon-beta production (GO:0032648) | 2.47194838 |
| 110 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.47069550 |
| 111 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.46544143 |
| 112 | activation of MAPKKK activity (GO:0000185) | 2.46544066 |
| 113 | regulation of necroptotic process (GO:0060544) | 2.46503240 |
| 114 | B cell mediated immunity (GO:0019724) | 2.45049548 |
| 115 | basic amino acid transport (GO:0015802) | 2.44035699 |
| 116 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.43430138 |
| 117 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.42344778 |
| 118 | regulation of leukocyte degranulation (GO:0043300) | 2.41945378 |
| 119 | cellular response to interferon-alpha (GO:0035457) | 2.41630476 |
| 120 | cellular response to virus (GO:0098586) | 2.41531843 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 2.40866582 |
| 122 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.40704519 |
| 123 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.39779023 |
| 124 | natural killer cell mediated immunity (GO:0002228) | 2.39779023 |
| 125 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.39339483 |
| 126 | lipoprotein transport (GO:0042953) | 2.38722454 |
| 127 | response to manganese ion (GO:0010042) | 2.38456972 |
| 128 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.38293066 |
| 129 | mature B cell differentiation (GO:0002335) | 2.38198684 |
| 130 | leukocyte aggregation (GO:0070486) | 2.37851031 |
| 131 | positive regulation of interleukin-6 production (GO:0032755) | 2.36741526 |
| 132 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.36200810 |
| 133 | lymphocyte chemotaxis (GO:0048247) | 2.35840630 |
| 134 | regulation of apoptotic cell clearance (GO:2000425) | 2.35764638 |
| 135 | positive regulation of leukocyte degranulation (GO:0043302) | 2.35731149 |
| 136 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.34878642 |
| 137 | microglial cell activation (GO:0001774) | 2.34569148 |
| 138 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.34471959 |
| 139 | pinocytosis (GO:0006907) | 2.32738218 |
| 140 | regulation of early endosome to late endosome transport (GO:2000641) | 2.32406665 |
| 141 | positive regulation of mast cell activation (GO:0033005) | 2.32169618 |
| 142 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.31091494 |
| 143 | protein localization to endosome (GO:0036010) | 2.30093645 |
| 144 | cellular response to interferon-gamma (GO:0071346) | 2.29820208 |
| 145 | T cell migration (GO:0072678) | 2.29156097 |
| 146 | NIK/NF-kappaB signaling (GO:0038061) | 2.28862951 |
| 147 | negative regulation of lipid storage (GO:0010888) | 2.28838803 |
| 148 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.28076591 |
| 149 | positive regulation of lipid storage (GO:0010884) | 2.27742691 |
| 150 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.27101102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.56124123 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.43923339 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.12821584 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.62851414 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.14559494 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13134307 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.12101294 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.10823354 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.98570116 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85139073 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.81933236 |
| 12 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.69873772 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.58276413 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.43373173 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42194311 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28483024 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.21839570 |
| 18 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15878010 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.13075662 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.00379464 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.00134753 |
| 22 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98370225 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97027889 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.92484242 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.89890640 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.85516442 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.82028722 |
| 28 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80900792 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80648888 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.80262216 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.77896540 |
| 32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.75765264 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.72099582 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.71866505 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.71701642 |
| 36 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.69098882 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67665118 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65641466 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65607338 |
| 40 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65516683 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59294154 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.57992599 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.55468152 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.54683383 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51054530 |
| 46 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49920923 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41551430 |
| 48 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39883653 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39570431 |
| 50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.39244858 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.38039001 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37427550 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35132682 |
| 54 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34303213 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33866859 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33635819 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33380103 |
| 58 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.33053956 |
| 59 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.32926900 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32912745 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.32721625 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31355656 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30572626 |
| 64 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30044143 |
| 65 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.28696260 |
| 66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.26782417 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25787420 |
| 68 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.25335301 |
| 69 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25196119 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24306444 |
| 71 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22487796 |
| 72 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.22310010 |
| 73 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.22310010 |
| 74 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.22310010 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.22025396 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20701157 |
| 77 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20166213 |
| 78 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.20023206 |
| 79 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19749729 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19389680 |
| 81 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17864645 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15410634 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15393177 |
| 84 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.15206738 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14642917 |
| 86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.14021049 |
| 87 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13712270 |
| 88 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13272424 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12611770 |
| 90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12430030 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12094448 |
| 92 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.10346396 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08914363 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08015342 |
| 95 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07980378 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07122303 |
| 97 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.05971303 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05800206 |
| 99 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05240788 |
| 100 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05161657 |
| 101 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03845073 |
| 102 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01953412 |
| 103 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01118201 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00851022 |
| 105 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00697437 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00293847 |
| 107 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.00132771 |
| 108 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00115119 |
| 109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99800159 |
| 110 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99800159 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99649098 |
| 112 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99521469 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99372835 |
| 114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98966455 |
| 115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98591784 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97719000 |
| 117 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.96090380 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94958953 |
| 119 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94274707 |
| 120 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93955165 |
| 121 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92626765 |
| 122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89956656 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89910969 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89568309 |
| 125 | MAF_26560356_Chip-Seq_TH2_Human | 0.89218897 |
| 126 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89113898 |
| 127 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89080241 |
| 128 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85087112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.79901456 |
| 2 | MP0003436_decreased_susceptibility_to | 3.16573885 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.10606261 |
| 4 | MP0005451_abnormal_body_composition | 3.09695625 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.02173022 |
| 6 | MP0004510_myositis | 2.88496031 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.81862474 |
| 8 | MP0006082_CNS_inflammation | 2.79926201 |
| 9 | MP0009840_abnormal_foam_cell | 2.78887710 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.72326139 |
| 11 | MP0005360_urolithiasis | 2.55549989 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.55102328 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.47453032 |
| 14 | MP0005387_immune_system_phenotype | 2.32941520 |
| 15 | MP0001790_abnormal_immune_system | 2.32941520 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.24118827 |
| 17 | MP0002419_abnormal_innate_immunity | 2.20423060 |
| 18 | MP0009785_altered_susceptibility_to | 2.18870751 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 2.14214708 |
| 20 | MP0000685_abnormal_immune_system | 2.09085053 |
| 21 | MP0009278_abnormal_bone_marrow | 2.02893698 |
| 22 | MP0005025_abnormal_response_to | 2.02603153 |
| 23 | MP0005076_abnormal_cell_differentiation | 1.97803728 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.96540700 |
| 25 | MP0001800_abnormal_humoral_immune | 1.96467199 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.88011431 |
| 27 | MP0003448_altered_tumor_morphology | 1.84695479 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.82959518 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.81568338 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.81568239 |
| 31 | MP0004947_skin_inflammation | 1.80877360 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.76428077 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.76101009 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.75693701 |
| 35 | MP0002723_abnormal_immune_serum | 1.72996546 |
| 36 | MP0003828_pulmonary_edema | 1.72773214 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.67376025 |
| 38 | MP0004858_abnormal_nervous_system | 1.61947466 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.60927217 |
| 40 | MP0003724_increased_susceptibility_to | 1.60496367 |
| 41 | MP0000604_amyloidosis | 1.60366639 |
| 42 | MP0001819_abnormal_immune_cell | 1.58421805 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.58403914 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.56910934 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.56250048 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.56091879 |
| 47 | MP0002405_respiratory_system_inflammati | 1.55886576 |
| 48 | MP0001849_ear_inflammation | 1.51723064 |
| 49 | MP0003091_abnormal_cell_migration | 1.51282997 |
| 50 | MP0003075_altered_response_to | 1.51128324 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.49304336 |
| 52 | MP0010307_abnormal_tumor_latency | 1.46348200 |
| 53 | MP0005023_abnormal_wound_healing | 1.43272408 |
| 54 | MP0008260_abnormal_autophagy | 1.42962889 |
| 55 | MP0005671_abnormal_response_to | 1.42600052 |
| 56 | MP0001958_emphysema | 1.40020411 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.39136499 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.38915755 |
| 59 | MP0004233_abnormal_muscle_weight | 1.34630207 |
| 60 | MP0008469_abnormal_protein_level | 1.31942003 |
| 61 | MP0000343_altered_response_to | 1.29678296 |
| 62 | MP0008004_abnormal_stomach_pH | 1.28890489 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.22896628 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.21734318 |
| 65 | MP0009764_decreased_sensitivity_to | 1.19750052 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 1.19501111 |
| 67 | MP0003045_fibrosis | 1.19357149 |
| 68 | MP0000858_altered_metastatic_potential | 1.19128711 |
| 69 | MP0003329_amyloid_beta_deposits | 1.18835013 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.15937696 |
| 71 | MP0000716_abnormal_immune_system | 1.14575690 |
| 72 | MP0005166_decreased_susceptibility_to | 1.14470973 |
| 73 | MP0003252_abnormal_bile_duct | 1.10602046 |
| 74 | MP0002398_abnormal_bone_marrow | 1.10339947 |
| 75 | MP0005409_darkened_coat_color | 1.07912912 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.07643055 |
| 77 | MP0001915_intracranial_hemorrhage | 1.07440281 |
| 78 | MP0005666_abnormal_adipose_tissue | 1.07032532 |
| 79 | MP0008961_abnormal_basal_metabolism | 1.03383329 |
| 80 | MP0003279_aneurysm | 1.02419029 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.99232371 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 0.99232371 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97093478 |
| 84 | MP0002722_abnormal_immune_system | 0.96798860 |
| 85 | MP0002429_abnormal_blood_cell | 0.94423077 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.94125529 |
| 87 | MP0000609_abnormal_liver_physiology | 0.94101597 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.93703242 |
| 89 | MP0005310_abnormal_salivary_gland | 0.93633999 |
| 90 | MP0000249_abnormal_blood_vessel | 0.93488129 |
| 91 | MP0000371_diluted_coat_color | 0.92603684 |
| 92 | MP0005390_skeleton_phenotype | 0.91922226 |
| 93 | MP0002254_reproductive_system_inflammat | 0.91010350 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.90195345 |
| 95 | MP0001853_heart_inflammation | 0.89724484 |
| 96 | MP0005164_abnormal_response_to | 0.89542498 |
| 97 | MP0001851_eye_inflammation | 0.88861898 |
| 98 | MP0005165_increased_susceptibility_to | 0.88306541 |
| 99 | MP0002166_altered_tumor_susceptibility | 0.88039197 |
| 100 | MP0006054_spinal_hemorrhage | 0.86608288 |
| 101 | MP0002168_other_aberrant_phenotype | 0.86315930 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.86032641 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.83999780 |
| 104 | MP0002933_joint_inflammation | 0.82949481 |
| 105 | MP0005083_abnormal_biliary_tract | 0.80288048 |
| 106 | MP0002006_tumorigenesis | 0.79775862 |
| 107 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79580463 |
| 108 | MP0004264_abnormal_extraembryonic_tissu | 0.79547502 |
| 109 | MP0000733_abnormal_muscle_development | 0.79504806 |
| 110 | MP0005621_abnormal_cell_physiology | 0.79321582 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.78503170 |
| 112 | MP0004019_abnormal_vitamin_homeostasis | 0.78055324 |
| 113 | MP0009763_increased_sensitivity_to | 0.77830137 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 0.77368266 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.77116234 |
| 116 | MP0010329_abnormal_lipoprotein_level | 0.77096143 |
| 117 | MP0000598_abnormal_liver_morphology | 0.76197227 |
| 118 | MP0003941_abnormal_skin_development | 0.75894070 |
| 119 | MP0004272_abnormal_basement_membrane | 0.75017022 |
| 120 | MP0005319_abnormal_enzyme/_coenzyme | 0.74744076 |
| 121 | MP0003690_abnormal_glial_cell | 0.74109026 |
| 122 | MP0009643_abnormal_urine_homeostasis | 0.71441329 |
| 123 | MP0004883_abnormal_blood_vessel | 0.70976627 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.70963920 |
| 125 | MP0001348_abnormal_lacrimal_gland | 0.68616025 |
| 126 | MP0000920_abnormal_myelination | 0.68219927 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.68193762 |
| 128 | MP0001216_abnormal_epidermal_layer | 0.67336444 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.65301819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.28793211 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.19648927 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 4.08876807 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 3.93051744 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.92909737 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.79463898 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 3.64946062 |
| 8 | Dysostosis multiplex (HP:0000943) | 3.41295860 |
| 9 | Myocardial infarction (HP:0001658) | 3.36433169 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 3.35091266 |
| 11 | Mucopolysacchariduria (HP:0008155) | 3.29029231 |
| 12 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.29029231 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.28319626 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.19022595 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.13210456 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.07294077 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.07294077 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.07294077 |
| 19 | Orchitis (HP:0100796) | 2.89194539 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 2.89159520 |
| 21 | Axonal loss (HP:0003447) | 2.84314183 |
| 22 | Myositis (HP:0100614) | 2.84012438 |
| 23 | Gingivitis (HP:0000230) | 2.83486073 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 2.81782842 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.80602772 |
| 26 | Peritonitis (HP:0002586) | 2.74189978 |
| 27 | Disinhibition (HP:0000734) | 2.62108600 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 2.58889049 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53123028 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53123028 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53123028 |
| 32 | Cerebral aneurysm (HP:0004944) | 2.49722493 |
| 33 | Glomerulonephritis (HP:0000099) | 2.49491450 |
| 34 | Recurrent fungal infections (HP:0002841) | 2.45556410 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.44610294 |
| 36 | Nasal polyposis (HP:0100582) | 2.43944325 |
| 37 | Increased connective tissue (HP:0009025) | 2.40779054 |
| 38 | Periodontitis (HP:0000704) | 2.39253334 |
| 39 | Stomatitis (HP:0010280) | 2.37536628 |
| 40 | Cervical subluxation (HP:0003308) | 2.35433026 |
| 41 | Pustule (HP:0200039) | 2.33627961 |
| 42 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.31590640 |
| 43 | Arterial thrombosis (HP:0004420) | 2.30663026 |
| 44 | Loss of speech (HP:0002371) | 2.30137991 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.30117009 |
| 46 | Nephritis (HP:0000123) | 2.27525461 |
| 47 | Abnormality of the nasal mucosa (HP:0000433) | 2.26770574 |
| 48 | Increased CSF protein (HP:0002922) | 2.26282868 |
| 49 | Abnormality of complement system (HP:0005339) | 2.25324216 |
| 50 | Vertebral compression fractures (HP:0002953) | 2.24902043 |
| 51 | Nuclear cataract (HP:0100018) | 2.24808717 |
| 52 | Recurrent skin infections (HP:0001581) | 2.24005967 |
| 53 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.23773122 |
| 54 | Upper motor neuron abnormality (HP:0002127) | 2.20503312 |
| 55 | Cellulitis (HP:0100658) | 2.20404531 |
| 56 | Keratoconjunctivitis (HP:0001096) | 2.18542054 |
| 57 | Esophageal varix (HP:0002040) | 2.17999869 |
| 58 | Hand muscle atrophy (HP:0009130) | 2.15373893 |
| 59 | Recurrent viral infections (HP:0004429) | 2.15084809 |
| 60 | Arterial tortuosity (HP:0005116) | 2.14930910 |
| 61 | Hematochezia (HP:0002573) | 2.13830592 |
| 62 | Hyperacusis (HP:0010780) | 2.13378506 |
| 63 | Complement deficiency (HP:0004431) | 2.12669658 |
| 64 | Vasculitis (HP:0002633) | 2.12534973 |
| 65 | Distal upper limb amyotrophy (HP:0007149) | 2.08876931 |
| 66 | Upper limb amyotrophy (HP:0009129) | 2.08876931 |
| 67 | Protrusio acetabuli (HP:0003179) | 2.05642465 |
| 68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.03819501 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 2.03819501 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.03489447 |
| 71 | Optic neuritis (HP:0100653) | 2.03489447 |
| 72 | Frequent falls (HP:0002359) | 2.03274863 |
| 73 | Xanthomatosis (HP:0000991) | 2.03237092 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.02705461 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.02705461 |
| 76 | Deep venous thrombosis (HP:0002625) | 1.99058024 |
| 77 | Menorrhagia (HP:0000132) | 1.98656045 |
| 78 | Gingival bleeding (HP:0000225) | 1.96324295 |
| 79 | Mitral stenosis (HP:0001718) | 1.95657498 |
| 80 | Basal ganglia calcification (HP:0002135) | 1.95482103 |
| 81 | Pulmonary infiltrates (HP:0002113) | 1.94840578 |
| 82 | Neuronal loss in central nervous system (HP:0002529) | 1.93284350 |
| 83 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.92658051 |
| 84 | Joint hemorrhage (HP:0005261) | 1.92654913 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 1.92287220 |
| 86 | Increased density of long bones (HP:0006392) | 1.92279169 |
| 87 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.91301383 |
| 88 | Asymmetric septal hypertrophy (HP:0001670) | 1.91281321 |
| 89 | Impaired platelet aggregation (HP:0003540) | 1.90812950 |
| 90 | Abnormal platelet function (HP:0011869) | 1.90812950 |
| 91 | Pathologic fracture (HP:0002756) | 1.89020220 |
| 92 | Vascular tortuosity (HP:0004948) | 1.88940530 |
| 93 | Abnormal platelet volume (HP:0011876) | 1.87317939 |
| 94 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86705694 |
| 95 | Obstructive lung disease (HP:0006536) | 1.86705694 |
| 96 | Spontaneous hematomas (HP:0007420) | 1.86679052 |
| 97 | Apathy (HP:0000741) | 1.86607384 |
| 98 | Global brain atrophy (HP:0002283) | 1.85996976 |
| 99 | Flat acetabular roof (HP:0003180) | 1.85719635 |
| 100 | Subacute progressive viral hepatitis (HP:0006572) | 1.85180173 |
| 101 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84852090 |
| 102 | Tetraparesis (HP:0002273) | 1.84317428 |
| 103 | Diminished motivation (HP:0000745) | 1.84210554 |
| 104 | Colitis (HP:0002583) | 1.84042564 |
| 105 | Gastrointestinal infarctions (HP:0005244) | 1.82985363 |
| 106 | Mitral valve prolapse (HP:0001634) | 1.82352030 |
| 107 | Distal lower limb muscle weakness (HP:0009053) | 1.82211741 |
| 108 | Coarse hair (HP:0002208) | 1.81697185 |
| 109 | Increased mean platelet volume (HP:0011877) | 1.81051477 |
| 110 | Urticaria (HP:0001025) | 1.80992843 |
| 111 | Aseptic necrosis (HP:0010885) | 1.80156506 |
| 112 | Amyloidosis (HP:0011034) | 1.78160418 |
| 113 | Achilles tendon contracture (HP:0001771) | 1.78108809 |
| 114 | Muscle fiber splitting (HP:0003555) | 1.78096427 |
| 115 | Increased serum ferritin (HP:0003281) | 1.78083380 |
| 116 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.77185314 |
| 117 | Spondylolisthesis (HP:0003302) | 1.76541280 |
| 118 | Thin bony cortex (HP:0002753) | 1.76306067 |
| 119 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.75187256 |
| 120 | Bone pain (HP:0002653) | 1.74983661 |
| 121 | Premature rupture of membranes (HP:0001788) | 1.74906433 |
| 122 | Insomnia (HP:0100785) | 1.73012329 |
| 123 | Absent frontal sinuses (HP:0002688) | 1.72809505 |
| 124 | Polygenic inheritance (HP:0010982) | 1.71903195 |
| 125 | Difficulty climbing stairs (HP:0003551) | 1.71364439 |
| 126 | Supranuclear gaze palsy (HP:0000605) | 1.67507782 |
| 127 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.64478247 |
| 128 | Slow saccadic eye movements (HP:0000514) | 1.63785199 |
| 129 | Asymmetry of the thorax (HP:0001555) | 1.63270973 |
| 130 | Fatigue (HP:0012378) | 1.63255553 |
| 131 | Thoracic kyphosis (HP:0002942) | 1.61549302 |
| 132 | Abnormality of the endocardium (HP:0004306) | 1.61121789 |
| 133 | Decreased motor nerve conduction velocity (HP:0003431) | 1.60991926 |
| 134 | Insidious onset (HP:0003587) | 1.60601468 |
| 135 | Termporal pattern (HP:0011008) | 1.60601468 |
| 136 | Thoracolumbar scoliosis (HP:0002944) | 1.60469974 |
| 137 | Ankyloglossia (HP:0010296) | 1.58695118 |
| 138 | Abnormality of the thoracic spine (HP:0100711) | 1.58112673 |
| 139 | Spinal cord lesions (HP:0100561) | 1.58062816 |
| 140 | Syringomyelia (HP:0003396) | 1.58062816 |
| 141 | Aneurysm (HP:0002617) | 1.57381781 |
| 142 | Polycythemia (HP:0001901) | 1.57133505 |
| 143 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.56387175 |
| 144 | Hyperparathyroidism (HP:0000843) | 1.56345736 |
| 145 | Abnormality of the Achilles tendon (HP:0005109) | 1.53990287 |
| 146 | Short nail (HP:0001799) | 1.53609434 |
| 147 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.53376490 |
| 148 | Long palpebral fissure (HP:0000637) | 1.53244693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.64606161 |
| 2 | PRPF4B | 3.44863102 |
| 3 | TRIB3 | 3.19214986 |
| 4 | MAP4K1 | 2.77577670 |
| 5 | MAP3K14 | 2.49723919 |
| 6 | TBK1 | 2.46019664 |
| 7 | RIPK1 | 2.44696378 |
| 8 | MAP3K10 | 2.33963839 |
| 9 | PKN2 | 2.27207026 |
| 10 | TYK2 | 2.25488487 |
| 11 | SMG1 | 2.17213410 |
| 12 | RIPK4 | 2.12696843 |
| 13 | CDK12 | 2.08285887 |
| 14 | BLK | 2.01687671 |
| 15 | BMX | 1.89885900 |
| 16 | JAK3 | 1.77687694 |
| 17 | JAK1 | 1.73601201 |
| 18 | GRK6 | 1.73363390 |
| 19 | STK10 | 1.71888322 |
| 20 | NME2 | 1.65357532 |
| 21 | CSK | 1.65351792 |
| 22 | PTK6 | 1.56156251 |
| 23 | EPHA2 | 1.55419464 |
| 24 | FGFR4 | 1.54062336 |
| 25 | DDR2 | 1.50722707 |
| 26 | EPHB1 | 1.43336864 |
| 27 | IKBKE | 1.40727643 |
| 28 | IKBKB | 1.39905717 |
| 29 | CDC42BPA | 1.37234636 |
| 30 | SIK2 | 1.36386463 |
| 31 | KIT | 1.35587641 |
| 32 | FGR | 1.32324600 |
| 33 | ZAP70 | 1.30858620 |
| 34 | MAP3K11 | 1.30589239 |
| 35 | TGFBR2 | 1.29598654 |
| 36 | IRAK3 | 1.29371011 |
| 37 | TTN | 1.27543771 |
| 38 | PDGFRA | 1.26587044 |
| 39 | MAP3K13 | 1.24881694 |
| 40 | LRRK2 | 1.24377815 |
| 41 | MAP3K9 | 1.23320826 |
| 42 | FGFR3 | 1.21173306 |
| 43 | IRAK2 | 1.19542640 |
| 44 | HCK | 1.17424702 |
| 45 | MATK | 1.11687959 |
| 46 | TAOK1 | 1.09899960 |
| 47 | IRAK4 | 1.09568936 |
| 48 | CHUK | 1.08976803 |
| 49 | PIM1 | 1.06533496 |
| 50 | KSR2 | 1.06166361 |
| 51 | EPHA3 | 1.02529870 |
| 52 | ALK | 1.00251266 |
| 53 | GRK7 | 1.00150163 |
| 54 | JAK2 | 0.99222017 |
| 55 | CSF1R | 0.98402250 |
| 56 | TAOK3 | 0.97505451 |
| 57 | YES1 | 0.95605977 |
| 58 | MOS | 0.93553219 |
| 59 | PTK2 | 0.91961470 |
| 60 | MAP2K3 | 0.91416386 |
| 61 | EEF2K | 0.89975106 |
| 62 | IRAK1 | 0.88359596 |
| 63 | PIM2 | 0.87526611 |
| 64 | SYK | 0.86099535 |
| 65 | MAP3K6 | 0.83174463 |
| 66 | CAMK1D | 0.82200492 |
| 67 | MARK3 | 0.82086919 |
| 68 | SCYL2 | 0.81933404 |
| 69 | MST1R | 0.79671444 |
| 70 | MAP3K5 | 0.77391283 |
| 71 | EGFR | 0.74087222 |
| 72 | BMPR2 | 0.74053864 |
| 73 | NEK9 | 0.73730430 |
| 74 | PRKG2 | 0.73666586 |
| 75 | STK24 | 0.73559794 |
| 76 | CDK6 | 0.73058820 |
| 77 | LCK | 0.73005326 |
| 78 | PAK4 | 0.72894789 |
| 79 | ERBB4 | 0.72324060 |
| 80 | MAP3K3 | 0.72181129 |
| 81 | TXK | 0.71714477 |
| 82 | SIK3 | 0.69862305 |
| 83 | KSR1 | 0.69583777 |
| 84 | CLK1 | 0.69496344 |
| 85 | GSK3A | 0.68695658 |
| 86 | SIK1 | 0.67696727 |
| 87 | PDGFRB | 0.67638485 |
| 88 | ABL2 | 0.67610374 |
| 89 | MAP3K1 | 0.67554554 |
| 90 | LATS2 | 0.67459465 |
| 91 | MARK2 | 0.66572291 |
| 92 | RPS6KA4 | 0.65919672 |
| 93 | CAMK1G | 0.64973677 |
| 94 | FES | 0.62676348 |
| 95 | CAMKK1 | 0.61900378 |
| 96 | PRKCH | 0.60563674 |
| 97 | RET | 0.59670407 |
| 98 | TRPM7 | 0.57522396 |
| 99 | MET | 0.57519645 |
| 100 | ITK | 0.56727808 |
| 101 | TAOK2 | 0.56453808 |
| 102 | ARAF | 0.53493702 |
| 103 | PDPK1 | 0.52880831 |
| 104 | STK3 | 0.52596984 |
| 105 | ABL1 | 0.52234577 |
| 106 | MTOR | 0.51481784 |
| 107 | SGK3 | 0.50053865 |
| 108 | ICK | 0.49730731 |
| 109 | LYN | 0.48160612 |
| 110 | BRD4 | 0.47922283 |
| 111 | BTK | 0.46431453 |
| 112 | DAPK2 | 0.46389372 |
| 113 | STK38 | 0.46130535 |
| 114 | DMPK | 0.43522463 |
| 115 | MAP3K8 | 0.42000849 |
| 116 | CDK4 | 0.41854400 |
| 117 | NTRK1 | 0.41023741 |
| 118 | MAP3K2 | 0.39924446 |
| 119 | TYRO3 | 0.39720418 |
| 120 | PDK1 | 0.38265007 |
| 121 | DYRK3 | 0.38070007 |
| 122 | RPS6KA2 | 0.37992205 |
| 123 | PRKD2 | 0.37901237 |
| 124 | HIPK2 | 0.37846455 |
| 125 | INSR | 0.37493623 |
| 126 | MELK | 0.36279407 |
| 127 | WNK1 | 0.35635594 |
| 128 | LATS1 | 0.35459404 |
| 129 | RPS6KC1 | 0.34667936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.82281508 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.61779693 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09318510 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08036263 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.94835705 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 1.82872198 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 1.78657251 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.74690623 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.70621297 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 1.69019834 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.68547139 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.65667219 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.60250747 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56551156 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.53828119 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47586487 |
| 17 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45309245 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44145079 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40569931 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.40120014 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.38622001 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35601484 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34655300 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.32408038 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31743994 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.30812764 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28619791 |
| 28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.27783305 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.27408293 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.26086407 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.25674260 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.24691791 |
| 33 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.22113390 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21403976 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20260643 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.16135809 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15721568 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14733168 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13340316 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.12492878 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12404317 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09835995 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.08973751 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.08421459 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07970457 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04235794 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03274010 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03126819 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03119540 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02545492 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 1.02212528 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.00887399 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.00880966 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99931524 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99151912 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99026899 |
| 57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94403533 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94307501 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94258721 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91193619 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90439073 |
| 62 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89482810 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 0.88049123 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85721520 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84273131 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83833501 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82943329 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82675696 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80878084 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80260171 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80051212 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79858664 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77045104 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76642106 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.75700204 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74648902 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74535301 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74006176 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.72655352 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71902494 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71880097 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71388167 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69350144 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68048711 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66659266 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66610017 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.65997658 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.65031283 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.64324028 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.63889343 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62832231 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61919628 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.61090702 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60329372 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.59974904 |
| 96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59952521 |
| 97 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59782610 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59460387 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58808722 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.58520953 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58490911 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57552149 |
| 103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55946301 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.55806289 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55760953 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55267229 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54677335 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53580770 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52426099 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51986553 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51487736 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50145329 |
| 113 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49845459 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49646942 |
| 115 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48904012 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48586992 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47599108 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.47585729 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46658034 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46078464 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45127845 |
| 122 | Asthma_Homo sapiens_hsa05310 | 0.44945394 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44060889 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41463170 |

